<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Life With ADHD &#187; ADHD Medications</title>
	<atom:link href="http://lifewithadhd.com/category/adhd-medications/feed" rel="self" type="application/rss+xml" />
	<link>http://lifewithadhd.com</link>
	<description>Father of a child with ADHD writes about ADHD news, information, and current ADD/ADHD research.</description>
	<lastBuildDate>Sat, 04 Feb 2012 09:13:41 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.6</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		
<!-- Excerpts generated using Auto Excerpt plugin, http://mr.hokya.com/auto-excerpt/ -->
	<item>
		<title>New British Ritalin Usage Advice</title>
		<link>http://lifewithadhd.com/adhd-medications/new-british-ritalin-usage-advice.php</link>
		<comments>http://lifewithadhd.com/adhd-medications/new-british-ritalin-usage-advice.php#comments</comments>
		<pubDate>Wed, 24 Sep 2008 13:15:03 +0000</pubDate>
		<dc:creator>ADHD Dad</dc:creator>
				<category><![CDATA[ADHD Medications]]></category>

		<guid isPermaLink="false">http://lifewithadhd.com/adhd-medications/new-british-ritalin-usage-advice.php</guid>
		<description><![CDATA[LONDON (AFP) — Parents should be taught how to cope with hyperactive youngsters and Ritalin should only be prescribed as a last resort and never given to the under-fives, a health watchdog said Wednesday.
The National Institute for Health and Clinical Excellence (NICE) has issued new guidelines on how to cope with unruly youngsters suffering from [...]]]></description>
			<content:encoded><![CDATA[LONDON (AFP) — Parents should be taught how to cope with hyperactive youngsters and Ritalin should only be prescribed as a last resort and never given to the under-fives, a health watchdog said Wednesday.
The National Institute for Health and Clinical Excellence (NICE) has issued new guidelines on how to cope with unruly youngsters suffering from attention deficit hyperactivity disorder (ADHD).
The disorder affects 365,000 children in Britain, and youngsters with ADHD are easily distracted, forgetful and have difficulty keeping still.
Doctors have prescribed Ritalin &#8212; which can cause insomnia, weight loss, nausea and an erratic heartbeat &#8212; to 37,000 children, but NICE says parents should instead be taught how to create a structured home environment, encourage attentiveness and deal properly wi <a href='http://lifewithadhd.com/adhd-medications/new-british-ritalin-usage-advice.php'>Read More</a>]]></content:encoded>
			<wfw:commentRss>http://lifewithadhd.com/adhd-medications/new-british-ritalin-usage-advice.php/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	
<!-- Excerpts generated using Auto Excerpt plugin, http://mr.hokya.com/auto-excerpt/ -->
	<item>
		<title>Focalin XR Approved by FDA for Treatment of ADHD</title>
		<link>http://lifewithadhd.com/adhd-medications/focalin-xr-approved-by-fda-for-treatment-of-adhd.php</link>
		<comments>http://lifewithadhd.com/adhd-medications/focalin-xr-approved-by-fda-for-treatment-of-adhd.php#comments</comments>
		<pubDate>Tue, 08 Jul 2008 11:32:41 +0000</pubDate>
		<dc:creator>ADHD Dad</dc:creator>
				<category><![CDATA[ADHD Medications]]></category>
		<category><![CDATA[ADD and ADHD]]></category>
		<category><![CDATA[Attention-deficit hyperactivity disorder]]></category>

		<guid isPermaLink="false">http://lifewithadhd.com/adhd-medications/focalin-xr-approved-by-fda-for-treatment-of-adhd.php</guid>
		<description><![CDATA[Novartis Pharmaceuticals Corporation announced that the U.S. Food and Drug Administration (FDA) has approved Focalin XR(TM) (dexmethylphenidate HCl) extended-release capsules for the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) in adults, adolescents and children.
&#8220;Focalin XR provides a new treatment option for adults, adolescents and children to address the many difficult symptoms of ADHD,&#8221; said Thomas Spencer,M.D., [...]]]></description>
			<content:encoded><![CDATA[Novartis Pharmaceuticals Corporation announced that the U.S. Food and Drug Administration (FDA) has approved Focalin XR(TM) (dexmethylphenidate HCl) extended-release capsules for the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) in adults, adolescents and children.
&#8220;Focalin XR provides a new treatment option for adults, adolescents and children to address the many difficult symptoms of ADHD,&#8221; said Thomas Spencer,M.D., Associate Professor of Psychiatry, Harvard Medical School and Assistant Director of the Pediatric Psychopharmacology Research Program at Massachusetts General Hospital. &#8220;Focalin XR provides patients with a treatment that starts working quickly to alleviate symptoms with the advantage of a once-daily dose.&#8221;
&#8220;We are pleased to introduce Focalin XR as  <a href='http://lifewithadhd.com/adhd-medications/focalin-xr-approved-by-fda-for-treatment-of-adhd.php'>Read More</a>]]></content:encoded>
			<wfw:commentRss>http://lifewithadhd.com/adhd-medications/focalin-xr-approved-by-fda-for-treatment-of-adhd.php/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

